ONC
BeiGene, Ltd.
356.00$
-0.8%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -32.4% | -87.9% | +22,179.2% | -16.8% | +116.0% | -27.9% | +280.8% | +20.4% | +73.7% | +55.0% | +40.2% | |
| – | +166.4% | +68.3% | +179.5% | +158.3% | -89.9% | -0.7% | +133.4% | +73.7% | +32.6% | +56.4% | +12.5% | |
| – | – | – | – | – | – | -33.3% | +324.6% | +11.7% | +84.1% | +54.7% | +45.3% | |
| – | +166.4% | +68.3% | +174.4% | +152.4% | +36.6% | +39.6% | +12.7% | +12.4% | +8.4% | +9.8% | +9.9% | |
| – | +5.5% | +174.9% | +211.5% | +212.1% | – | – | +65.0% | +29.1% | +17.9% | +21.4% | +13.7% | |
| – | +5.5% | +174.9% | +212.7% | +212.3% | +570.9% | +44.0% | +29.2% | +19.1% | +12.6% | +15.1% | +11.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -65.4% | -68.8% | +972.6% | +239.5% | – | – | – | – | -91.7% | +399.7% | +167.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -154.2% | – | +4,038.9% | -806.8% | – | +48.7% | +84.9% | +122.5% | +30.6% | +100.1% | +16.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.